Literature DB >> 21779854

Longitudinal study of bone mineral density in children with idiopathic hypercalciuria.

Maria Goretti Moreira Guimarães Penido1, Marcelo de Sousa Tavares, Mariana Campos Linhares, Ana Carolina Silva Barbosa, Maarmed Cunha.   

Abstract

Children with idiopathic hypercalciuria (IH) may have a reduced bone mineral density (BMD), which could impact on bone health in adulthood. There is currently no strong evidence for a preferred treatment of such children. The aim of our study was to evaluate the BMD z-score before and after treating children and adolescents with IH with potassium citrate and thiazides. The study consisted of a historical cohort of 80 pediatric patients who were evaluated between October 1989 and November 2010. Bone scanning and densitometry measurements were made with dual-emission X-ray absorptiometry. Lumbar-spine BMD (g/cm(2)) and BMD z-score were evaluated before and after treatment. The t test and Mann-Whitney U test were used for statistical analysis. Forty-three boys and 37 girls were followed for a median time of 6.0 years. Median calcium excretion before and after treatment was 5.0 and 2.6 mg/kg/24 h, respectively. The BMD z-score changed significantly from -0.763 ± 0.954 (mean ± SD) to -0.537 ± 0.898 (p < 0.0001) before and after treatment, respectively. The BMD z-score of the patients improved with treatment, suggesting a beneficial effect and potential need for treatment. However, the lack of a control group points to the need for future studies to corroborate this outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21779854     DOI: 10.1007/s00467-011-1952-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  44 in total

1.  Bone mineral density in pediatric patients with idiopathic hypercalciuria.

Authors:  V García-Nieto; C Ferrández; M Monge; M de Sequera; M D Rodrigo
Journal:  Pediatr Nephrol       Date:  1997-10       Impact factor: 3.714

2.  Childhood bone mass acquisition and peak bone mass may not be important determinants of bone mass in late adulthood.

Authors:  Rachel I Gafni; Jeffrey Baron
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

3.  Bone loss in children with idiopathic hypercalciuria.

Authors:  V García-Nieto; J F Navarro; C Ferrández
Journal:  Nephron       Date:  1998       Impact factor: 2.847

4.  Clinical presentation and natural course of idiopathic hypercalciuria in children.

Authors:  C Polito; A La Manna; F Cioce; J Villani; B Nappi; R Di Toro
Journal:  Pediatr Nephrol       Date:  2000-12       Impact factor: 3.714

5.  Sodium transport and bone mineral density in hypercalciuria with thiazide treatment.

Authors:  G S Reusz; M Dobos; B Vásárhelyi; P Sallay; A Szabó; C Horváth; A Szabó; D J Byrd; H H Thole; T Tulassay
Journal:  Pediatr Nephrol       Date:  1998-01       Impact factor: 3.714

6.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

7.  Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers.

Authors:  Michael Freundlich; Evelyn Alonzo; Ezequiel Bellorin-Font; Jose R Weisinger
Journal:  Nephrol Dial Transplant       Date:  2002-08       Impact factor: 5.992

8.  In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo.

Authors:  H Zhou; P Choong; R McCarthy; S T Chou; T J Martin; K W Ng
Journal:  J Bone Miner Res       Date:  1994-09       Impact factor: 6.741

9.  Metabolic risk factors in children with kidney stone disease.

Authors:  Francisco R Spivacow; Armando L Negri; Elisa E del Valle; Irene Calviño; Erich Fradinger; José R Zanchetta
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

10.  [Idiopathic hypercalciuria: presentation of 471 cases]

Authors:  M G Penido; J S Diniz; M L Moreira; A L Tupinambá; A França; B H Andrade; M F Souto
Journal:  J Pediatr (Rio J)       Date:  2001 Mar-Apr       Impact factor: 2.197

View more
  4 in total

Review 1.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

2.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

Review 3.  A contemporary therapeutic approach to bone disease in beta-thalassemia - a review.

Authors:  Dimitrios Stefanopoulos; Nikolaos A Papaioannou; Athanassios G Papavassiliou; George Mastorakos; Andromachi Vryonidou; Aikaterini Michou; Ismene A Dontas; George Lyritis; Eva Kassi; Symeon Tournis
Journal:  J Frailty Sarcopenia Falls       Date:  2018-03-01

4.  Effect of Vitamin D Treatment on Dynamics of Stones Formation in the Urinary Tract and Bone Density in Children with Idiopathic Hypercalciuria.

Authors:  Joanna Milart; Aneta Lewicka; Katarzyna Jobs; Agata Wawrzyniak; Małgorzata Majder-Łopatka; Bolesław Kalicki
Journal:  Nutrients       Date:  2020-08-20       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.